Forma Therapeutics Holdings, Inc.
(NASDAQ GM: FMTX)
Rigrodsky Law, P.A. is investigating Forma Therapeutics Holdings, Inc. (“Forma”) regarding possible breaches of fiduciary duties and other violations of law related to Forma’s agreement to be acquired by Novo Nordisk A/S. Under the terms of the agreement, Forma’s shareholders will receive $20.00 per share.